Skip to content

Stellarex AB35SX050200135Recalls & reported problems

Spectranetics Corporation · Stellarex 0.035 OTW Drug-coated Angioplasty Balloon (5mm x 200mm) x 135cm · Class 3

All models of Stellarex (8)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813132026967), received between Oct 25, 2021 and Oct 25, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Rupture” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Rupture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 25, 2021Material Rupture; Material Rupture

    THE STELLAREX DEVICE WAS USED TO TREAT A MODERATELY TORTUOUS AND SEVERELY CALCIFIED DISTAL SFA. DURING INFLATION AT LESS THAN 10 ATM, THE BALLOON BURST. THE BALLOON WAS REMOVED OVER THE WIRE AND IN ONE PIECE. THE PROCEDURE WAS COMPLETED WITH A NEW STELLAREX DEVICE. NO PATIENT INJURY REPORTED. THIS PRODUCT PROBLEM IS BEING SUBMITTED PER FDA REQUEST BECAUSE THE BALLOON RUPTURED BELOW RBP.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12693657 ↗

Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices

All Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page